Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_assertion type Assertion NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_head.
- NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_assertion description "[Fibroblast growth factor (FGF) signaling can bypass the requirement for estrogen receptor (ER) activation in the growth of ER-positive (ER+) breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.
- NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_assertion evidence source_evidence_literature NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.
- NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_assertion SIO_000772 16682955 NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.
- NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_assertion wasDerivedFrom befree-2016 NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.
- NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_assertion wasGeneratedBy ECO_0000203 NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.